CD30 ligand could be a new therapeutic target for central nervous system autoimmunity
2021 ◽
Vol 25
(8)
◽
pp. 659-676
2019 ◽
Vol 199
(6)
◽
pp. 689-691
◽
2019 ◽
Vol 14
(11)
◽
pp. 1893
◽
2020 ◽
Vol 24
(7)
◽
pp. 639-653
2020 ◽
Vol 13
(2)
◽
pp. 365-371
◽